ENTITY

TxCell SA (TXCL FP)

Analysis

Health Care • France

TxCell SA researches and develops biotechnological products. The Company offers cell-based immunotherapies for the treatment of chronic inflammatory, bowel, joint, and neurological diseases.

Refresh

Focused

No publications yet

There aren’t any broker reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00